Global Biosimilar Drug Market Insights and Forecast to 2028

Global Biosimilar Drug Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Biosimilar Drug Product Introduction
1.2 Market by Type
1.2.1 Global Biosimilar Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Injection
1.2.3 Tablets
1.2.4 Other Types
1.3 Market by Application
1.3.1 Global Biosimilar Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Ankylosing Spondylitis
1.3.3 Tumor
1.3.4 Rheumatoid Arthrtis
1.3.5 Cardiovascular
1.3.6 Other Application
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Biosimilar Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Biosimilar Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Biosimilar Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Biosimilar Drug Sales by Region
2.4.1 Global Biosimilar Drug Sales by Region (2017-2022)
2.4.2 Global Sales Biosimilar Drug by Region (2023-2028)
2.5 Global Biosimilar Drug Revenue by Region
2.5.1 Global Biosimilar Drug Revenue by Region (2017-2022)
2.5.2 Global Biosimilar Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Biosimilar Drug Sales by Manufacturers
3.1.1 Global Top Biosimilar Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Biosimilar Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Biosimilar Drug in 2021
3.2 Global Biosimilar Drug Revenue by Manufacturers
3.2.1 Global Biosimilar Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Biosimilar Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Biosimilar Drug Revenue in 2021
3.3 Global Biosimilar Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Biosimilar Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Biosimilar Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Biosimilar Drug Sales by Type
4.1.1 Global Biosimilar Drug Historical Sales by Type (2017-2022)
4.1.2 Global Biosimilar Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Biosimilar Drug Sales Market Share by Type (2017-2028)
4.2 Global Biosimilar Drug Revenue by Type
4.2.1 Global Biosimilar Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Biosimilar Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Biosimilar Drug Revenue Market Share by Type (2017-2028)
4.3 Global Biosimilar Drug Price by Type
4.3.1 Global Biosimilar Drug Price by Type (2017-2022)
4.3.2 Global Biosimilar Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Biosimilar Drug Sales by Application
5.1.1 Global Biosimilar Drug Historical Sales by Application (2017-2022)
5.1.2 Global Biosimilar Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Biosimilar Drug Sales Market Share by Application (2017-2028)
5.2 Global Biosimilar Drug Revenue by Application
5.2.1 Global Biosimilar Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Biosimilar Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Biosimilar Drug Revenue Market Share by Application (2017-2028)
5.3 Global Biosimilar Drug Price by Application
5.3.1 Global Biosimilar Drug Price by Application (2017-2022)
5.3.2 Global Biosimilar Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Biosimilar Drug Market Size by Type
6.1.1 North America Biosimilar Drug Sales by Type (2017-2028)
6.1.2 North America Biosimilar Drug Revenue by Type (2017-2028)
6.2 North America Biosimilar Drug Market Size by Application
6.2.1 North America Biosimilar Drug Sales by Application (2017-2028)
6.2.2 North America Biosimilar Drug Revenue by Application (2017-2028)
6.3 North America Biosimilar Drug Market Size by Country
6.3.1 North America Biosimilar Drug Sales by Country (2017-2028)
6.3.2 North America Biosimilar Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Biosimilar Drug Market Size by Type
7.1.1 Europe Biosimilar Drug Sales by Type (2017-2028)
7.1.2 Europe Biosimilar Drug Revenue by Type (2017-2028)
7.2 Europe Biosimilar Drug Market Size by Application
7.2.1 Europe Biosimilar Drug Sales by Application (2017-2028)
7.2.2 Europe Biosimilar Drug Revenue by Application (2017-2028)
7.3 Europe Biosimilar Drug Market Size by Country
7.3.1 Europe Biosimilar Drug Sales by Country (2017-2028)
7.3.2 Europe Biosimilar Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Biosimilar Drug Market Size by Type
8.1.1 Asia Pacific Biosimilar Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Biosimilar Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Biosimilar Drug Market Size by Application
8.2.1 Asia Pacific Biosimilar Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Biosimilar Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Biosimilar Drug Market Size by Region
8.3.1 Asia Pacific Biosimilar Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Biosimilar Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Biosimilar Drug Market Size by Type
9.1.1 Latin America Biosimilar Drug Sales by Type (2017-2028)
9.1.2 Latin America Biosimilar Drug Revenue by Type (2017-2028)
9.2 Latin America Biosimilar Drug Market Size by Application
9.2.1 Latin America Biosimilar Drug Sales by Application (2017-2028)
9.2.2 Latin America Biosimilar Drug Revenue by Application (2017-2028)
9.3 Latin America Biosimilar Drug Market Size by Country
9.3.1 Latin America Biosimilar Drug Sales by Country (2017-2028)
9.3.2 Latin America Biosimilar Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Biosimilar Drug Market Size by Type
10.1.1 Middle East and Africa Biosimilar Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Biosimilar Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Biosimilar Drug Market Size by Application
10.2.1 Middle East and Africa Biosimilar Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Biosimilar Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Biosimilar Drug Market Size by Country
10.3.1 Middle East and Africa Biosimilar Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Biosimilar Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 CP Guojian Pharma
11.1.1 CP Guojian Pharma Corporation Information
11.1.2 CP Guojian Pharma Overview
11.1.3 CP Guojian Pharma Biosimilar Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 CP Guojian Pharma Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 CP Guojian Pharma Recent Developments
11.2 Biotech Pharma
11.2.1 Biotech Pharma Corporation Information
11.2.2 Biotech Pharma Overview
11.2.3 Biotech Pharma Biosimilar Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Biotech Pharma Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Biotech Pharma Recent Developments
11.3 Celgen Pharma
11.3.1 Celgen Pharma Corporation Information
11.3.2 Celgen Pharma Overview
11.3.3 Celgen Pharma Biosimilar Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Celgen Pharma Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Celgen Pharma Recent Developments
11.4 Henlius
11.4.1 Henlius Corporation Information
11.4.2 Henlius Overview
11.4.3 Henlius Biosimilar Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Henlius Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Henlius Recent Developments
11.5 Amgen
11.5.1 Amgen Corporation Information
11.5.2 Amgen Overview
11.5.3 Amgen Biosimilar Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Amgen Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Amgen Recent Developments
11.6 Eli Lilly
11.6.1 Eli Lilly Corporation Information
11.6.2 Eli Lilly Overview
11.6.3 Eli Lilly Biosimilar Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Eli Lilly Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Eli Lilly Recent Developments
11.7 Sandoz
11.7.1 Sandoz Corporation Information
11.7.2 Sandoz Overview
11.7.3 Sandoz Biosimilar Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Sandoz Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sandoz Recent Developments
11.8 Changchun High Tech
11.8.1 Changchun High Tech Corporation Information
11.8.2 Changchun High Tech Overview
11.8.3 Changchun High Tech Biosimilar Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Changchun High Tech Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Changchun High Tech Recent Developments
11.9 Innovent
11.9.1 Innovent Corporation Information
11.9.2 Innovent Overview
11.9.3 Innovent Biosimilar Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Innovent Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Innovent Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Biosimilar Drug Industry Chain Analysis
12.2 Biosimilar Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Biosimilar Drug Production Mode & Process
12.4 Biosimilar Drug Sales and Marketing
12.4.1 Biosimilar Drug Sales Channels
12.4.2 Biosimilar Drug Distributors
12.5 Biosimilar Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Biosimilar Drug Industry Trends
13.2 Biosimilar Drug Market Drivers
13.3 Biosimilar Drug Market Challenges
13.4 Biosimilar Drug Market Restraints
14 Key Findings in The Global Biosimilar Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Biosimilar Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Injection
Table 3. Major Manufacturers of Tablets
Table 4. Major Manufacturers of Other Types
Table 5. Global Biosimilar Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Biosimilar Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Biosimilar Drug Sales by Region (2017-2022) & (K Dose)
Table 8. Global Biosimilar Drug Sales Market Share by Region (2017-2022)
Table 9. Global Biosimilar Drug Sales by Region (2023-2028) & (K Dose)
Table 10. Global Biosimilar Drug Sales Market Share by Region (2023-2028)
Table 11. Global Biosimilar Drug Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Biosimilar Drug Revenue Market Share by Region (2017-2022)
Table 13. Global Biosimilar Drug Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Biosimilar Drug Revenue Market Share by Region (2023-2028)
Table 15. Global Biosimilar Drug Sales by Manufacturers (2017-2022) & (K Dose)
Table 16. Global Biosimilar Drug Sales Share by Manufacturers (2017-2022)
Table 17. Global Biosimilar Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Biosimilar Drug Revenue Share by Manufacturers (2017-2022)
Table 19. Biosimilar Drug Price by Manufacturers (2017-2022) &(USD/Dose)
Table 20. Global Biosimilar Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Biosimilar Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Drug as of 2021)
Table 22. Biosimilar Drug Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Biosimilar Drug Product Offered
Table 24. Date of Manufacturers Enter into Biosimilar Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Biosimilar Drug Sales by Type (2017-2022) & (K Dose)
Table 27. Global Biosimilar Drug Sales by Type (2023-2028) & (K Dose)
Table 28. Global Biosimilar Drug Sales Share by Type (2017-2022)
Table 29. Global Biosimilar Drug Sales Share by Type (2023-2028)
Table 30. Global Biosimilar Drug Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Biosimilar Drug Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Biosimilar Drug Revenue Share by Type (2017-2022)
Table 33. Global Biosimilar Drug Revenue Share by Type (2023-2028)
Table 34. Biosimilar Drug Price by Type (2017-2022) & (USD/Dose)
Table 35. Global Biosimilar Drug Price Forecast by Type (2023-2028) & (USD/Dose)
Table 36. Global Biosimilar Drug Sales by Application (2017-2022) & (K Dose)
Table 37. Global Biosimilar Drug Sales by Application (2023-2028) & (K Dose)
Table 38. Global Biosimilar Drug Sales Share by Application (2017-2022)
Table 39. Global Biosimilar Drug Sales Share by Application (2023-2028)
Table 40. Global Biosimilar Drug Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Biosimilar Drug Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Biosimilar Drug Revenue Share by Application (2017-2022)
Table 43. Global Biosimilar Drug Revenue Share by Application (2023-2028)
Table 44. Biosimilar Drug Price by Application (2017-2022) & (USD/Dose)
Table 45. Global Biosimilar Drug Price Forecast by Application (2023-2028) & (USD/Dose)
Table 46. North America Biosimilar Drug Sales by Type (2017-2022) & (K Dose)
Table 47. North America Biosimilar Drug Sales by Type (2023-2028) & (K Dose)
Table 48. North America Biosimilar Drug Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Biosimilar Drug Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Biosimilar Drug Sales by Application (2017-2022) & (K Dose)
Table 51. North America Biosimilar Drug Sales by Application (2023-2028) & (K Dose)
Table 52. North America Biosimilar Drug Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Biosimilar Drug Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Biosimilar Drug Sales by Country (2017-2022) & (K Dose)
Table 55. North America Biosimilar Drug Sales by Country (2023-2028) & (K Dose)
Table 56. North America Biosimilar Drug Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Biosimilar Drug Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Biosimilar Drug Sales by Type (2017-2022) & (K Dose)
Table 59. Europe Biosimilar Drug Sales by Type (2023-2028) & (K Dose)
Table 60. Europe Biosimilar Drug Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Biosimilar Drug Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Biosimilar Drug Sales by Application (2017-2022) & (K Dose)
Table 63. Europe Biosimilar Drug Sales by Application (2023-2028) & (K Dose)
Table 64. Europe Biosimilar Drug Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Biosimilar Drug Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Biosimilar Drug Sales by Country (2017-2022) & (K Dose)
Table 67. Europe Biosimilar Drug Sales by Country (2023-2028) & (K Dose)
Table 68. Europe Biosimilar Drug Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Biosimilar Drug Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Biosimilar Drug Sales by Type (2017-2022) & (K Dose)
Table 71. Asia Pacific Biosimilar Drug Sales by Type (2023-2028) & (K Dose)
Table 72. Asia Pacific Biosimilar Drug Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Biosimilar Drug Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Biosimilar Drug Sales by Application (2017-2022) & (K Dose)
Table 75. Asia Pacific Biosimilar Drug Sales by Application (2023-2028) & (K Dose)
Table 76. Asia Pacific Biosimilar Drug Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Biosimilar Drug Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Biosimilar Drug Sales by Region (2017-2022) & (K Dose)
Table 79. Asia Pacific Biosimilar Drug Sales by Region (2023-2028) & (K Dose)
Table 80. Asia Pacific Biosimilar Drug Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Biosimilar Drug Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Biosimilar Drug Sales by Type (2017-2022) & (K Dose)
Table 83. Latin America Biosimilar Drug Sales by Type (2023-2028) & (K Dose)
Table 84. Latin America Biosimilar Drug Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Biosimilar Drug Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Biosimilar Drug Sales by Application (2017-2022) & (K Dose)
Table 87. Latin America Biosimilar Drug Sales by Application (2023-2028) & (K Dose)
Table 88. Latin America Biosimilar Drug Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Biosimilar Drug Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Biosimilar Drug Sales by Country (2017-2022) & (K Dose)
Table 91. Latin America Biosimilar Drug Sales by Country (2023-2028) & (K Dose)
Table 92. Latin America Biosimilar Drug Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Biosimilar Drug Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Biosimilar Drug Sales by Type (2017-2022) & (K Dose)
Table 95. Middle East and Africa Biosimilar Drug Sales by Type (2023-2028) & (K Dose)
Table 96. Middle East and Africa Biosimilar Drug Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Biosimilar Drug Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Biosimilar Drug Sales by Application (2017-2022) & (K Dose)
Table 99. Middle East and Africa Biosimilar Drug Sales by Application (2023-2028) & (K Dose)
Table 100. Middle East and Africa Biosimilar Drug Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Biosimilar Drug Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Biosimilar Drug Sales by Country (2017-2022) & (K Dose)
Table 103. Middle East and Africa Biosimilar Drug Sales by Country (2023-2028) & (K Dose)
Table 104. Middle East and Africa Biosimilar Drug Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Biosimilar Drug Revenue by Country (2023-2028) & (US$ Million)
Table 106. CP Guojian Pharma Corporation Information
Table 107. CP Guojian Pharma Description and Major Businesses
Table 108. CP Guojian Pharma Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 109. CP Guojian Pharma Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. CP Guojian Pharma Recent Developments
Table 111. Biotech Pharma Corporation Information
Table 112. Biotech Pharma Description and Major Businesses
Table 113. Biotech Pharma Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 114. Biotech Pharma Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Biotech Pharma Recent Developments
Table 116. Celgen Pharma Corporation Information
Table 117. Celgen Pharma Description and Major Businesses
Table 118. Celgen Pharma Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 119. Celgen Pharma Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Celgen Pharma Recent Developments
Table 121. Henlius Corporation Information
Table 122. Henlius Description and Major Businesses
Table 123. Henlius Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 124. Henlius Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Henlius Recent Developments
Table 126. Amgen Corporation Information
Table 127. Amgen Description and Major Businesses
Table 128. Amgen Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 129. Amgen Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Amgen Recent Developments
Table 131. Eli Lilly Corporation Information
Table 132. Eli Lilly Description and Major Businesses
Table 133. Eli Lilly Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 134. Eli Lilly Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Eli Lilly Recent Developments
Table 136. Sandoz Corporation Information
Table 137. Sandoz Description and Major Businesses
Table 138. Sandoz Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 139. Sandoz Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Sandoz Recent Developments
Table 141. Changchun High Tech Corporation Information
Table 142. Changchun High Tech Description and Major Businesses
Table 143. Changchun High Tech Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 144. Changchun High Tech Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Changchun High Tech Recent Developments
Table 146. Innovent Corporation Information
Table 147. Innovent Description and Major Businesses
Table 148. Innovent Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 149. Innovent Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Innovent Recent Developments
Table 151. Key Raw Materials Lists
Table 152. Raw Materials Key Suppliers Lists
Table 153. Biosimilar Drug Distributors List
Table 154. Biosimilar Drug Customers List
Table 155. Biosimilar Drug Market Trends
Table 156. Biosimilar Drug Market Drivers
Table 157. Biosimilar Drug Market Challenges
Table 158. Biosimilar Drug Market Restraints
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Biosimilar Drug Product Picture
Figure 3. Global Biosimilar Drug Market Share by Type in 2021 & 2028
Figure 3. Injection Product Picture
Figure 4. Tablets Product Picture
Figure 5. Other Types Product Picture
Figure 6. Global Biosimilar Drug Market Share by Application in 2021 & 2028
Figure 7. Ankylosing Spondylitis
Figure 8. Tumor
Figure 9. Rheumatoid Arthrtis
Figure 10. Cardiovascular
Figure 11. Other Application
Figure 12. Biosimilar Drug Report Years Considered
Figure 13. Global Biosimilar Drug Sales 2017-2028 (K Dose)
Figure 14. Global Biosimilar Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Biosimilar Drug Revenue 2017-2028 (US$ Million)
Figure 16. Global Biosimilar Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Biosimilar Drug Sales Market Share by Region (2017-2022)
Figure 18. Global Biosimilar Drug Sales Market Share by Region (2023-2028)
Figure 19. North America Biosimilar Drug Sales YoY (2017-2028) & (K Dose)
Figure 20. North America Biosimilar Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Biosimilar Drug Sales YoY (2017-2028) & (K Dose)
Figure 22. Europe Biosimilar Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Biosimilar Drug Sales YoY (2017-2028) & (K Dose)
Figure 24. Asia-Pacific Biosimilar Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Biosimilar Drug Sales YoY (2017-2028) & (K Dose)
Figure 26. Latin America Biosimilar Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Biosimilar Drug Sales YoY (2017-2028) & (K Dose)
Figure 28. Middle East & Africa Biosimilar Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Biosimilar Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Biosimilar Drug in the World: Market Share by Biosimilar Drug Revenue in 2021
Figure 31. Global Biosimilar Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Biosimilar Drug Sales Market Share by Type (2017-2028)
Figure 33. Global Biosimilar Drug Revenue Market Share by Type (2017-2028)
Figure 34. Global Biosimilar Drug Sales Market Share by Application (2017-2028)
Figure 35. Global Biosimilar Drug Revenue Market Share by Application (2017-2028)
Figure 36. North America Biosimilar Drug Sales Market Share by Type (2017-2028)
Figure 37. North America Biosimilar Drug Revenue Market Share by Type (2017-2028)
Figure 38. North America Biosimilar Drug Sales Market Share by Application (2017-2028)
Figure 39. North America Biosimilar Drug Revenue Market Share by Application (2017-2028)
Figure 40. North America Biosimilar Drug Sales Share by Country (2017-2028)
Figure 41. North America Biosimilar Drug Revenue Share by Country (2017-2028)
Figure 42. U.S. Biosimilar Drug Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Biosimilar Drug Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Biosimilar Drug Sales Market Share by Type (2017-2028)
Figure 45. Europe Biosimilar Drug Revenue Market Share by Type (2017-2028)
Figure 46. Europe Biosimilar Drug Sales Market Share by Application (2017-2028)
Figure 47. Europe Biosimilar Drug Revenue Market Share by Application (2017-2028)
Figure 48. Europe Biosimilar Drug Sales Share by Country (2017-2028)
Figure 49. Europe Biosimilar Drug Revenue Share by Country (2017-2028)
Figure 50. Germany Biosimilar Drug Revenue (2017-2028) & (US$ Million)
Figure 51. France Biosimilar Drug Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. Biosimilar Drug Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Biosimilar Drug Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Biosimilar Drug Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Biosimilar Drug Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific Biosimilar Drug Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific Biosimilar Drug Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Biosimilar Drug Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Biosimilar Drug Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Biosimilar Drug Revenue Share by Region (2017-2028)
Figure 61. China Biosimilar Drug Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Biosimilar Drug Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Biosimilar Drug Revenue (2017-2028) & (US$ Million)
Figure 64. India Biosimilar Drug Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Biosimilar Drug Revenue (2017-2028) & (US$ Million)
Figure 66. China Taiwan Biosimilar Drug Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Biosimilar Drug Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Biosimilar Drug Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia Biosimilar Drug Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Biosimilar Drug Sales Market Share by Type (2017-2028)
Figure 71. Latin America Biosimilar Drug Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Biosimilar Drug Sales Market Share by Application (2017-2028)
Figure 73. Latin America Biosimilar Drug Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Biosimilar Drug Sales Share by Country (2017-2028)
Figure 75. Latin America Biosimilar Drug Revenue Share by Country (2017-2028)
Figure 76. Mexico Biosimilar Drug Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Biosimilar Drug Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Biosimilar Drug Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Biosimilar Drug Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Biosimilar Drug Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Biosimilar Drug Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Biosimilar Drug Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Biosimilar Drug Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Biosimilar Drug Revenue Share by Country (2017-2028)
Figure 85. Turkey Biosimilar Drug Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Biosimilar Drug Revenue (2017-2028) & (US$ Million)
Figure 87. UAE Biosimilar Drug Revenue (2017-2028) & (US$ Million)
Figure 88. Biosimilar Drug Value Chain
Figure 89. Biosimilar Drug Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147

According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......

Global Biosimilar Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......

Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147

According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......

Global Biosimilars Market Research Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......

Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs